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Phenotyping the Microcirculation With 
Contrast-Enhanced Ultrasound
To the Editor:
In their interesting review, Struijker-Boudier et al1 provide a criti-
cal appraisal of current methods to study the microcirculation. In the 
extensive review, contrast-enhanced ultrasonography (CEU) remains 
undiscussed, whereas this method holds great promise as a tool in 
hypertension research.
CEU is an imaging tool that enables quantification of microvascu-
lar perfusion in organs and tissues.2–5 It uses gas-filled microbubbles, 
typically with a lipid shell, that are inert, remain entirely within the 
vascular space, and possess an intravascular rheology similar to that 
of erythrocytes.2 Therefore, they specifically enhance imaging of the 
(micro-)vessels. During intravenous infusion of these microbubbles 
and attainment of a steady state, microbubbles can be destroyed 
with high-energy ultrasound. Subsequently, new microbubbles will 
flow into the region of interest. The rate of microbubble replenish-
ment represents microvascular flow velocity. When the microbubbles 
are fully replenished, a plateau of video intensity is reached corre-
sponding with the relative microvascular blood volume. The product 
of microvascular flow velocity and microvascular blood volume is 
a measure of microvascular perfusion.3 Because microbubbles are 
distributed throughout the entire vasculature, simultaneous study of 
microvascular beds of different organs (eg, skeletal muscle, the heart, 
and kidney) is possible.4
Surprisingly, although CEU has been used to study the pathophys-
iological role of microvascular perfusion in obesity-related insulin 
resistance and other metabolic syndrome characteristics, no data are 
available on the relation with blood pressure/hypertension. In a post 
hoc analysis of a recent study measuring microvascular perfusion in 
skeletal muscle with CEU,5 we assessed the association of muscle 
microvascular perfusion with blood pressure. In this healthy, nor-
motensive group, blood pressure was inversely related with skeletal 
muscle perfusion in the forearm (systolic blood pressure β=−0.50, 
P=0.05; diastolic blood pressure β=−0.49, P=0.03; and mean arterial 
pressure β=−0.53, P=0.02) after adjustment for sex and age. These 
relationships did not change after additional adjustment for body 
mass index. This post hoc analysis shows the potential of CEU to be 
applied in blood pressure and hypertension research.
Apart from the mentioned imaging capabilities, microbubbles can 
be targeted using antibodies and loaded with interventional drugs. 
Therefore, CEU combines the assets of intravital microscopy, cap-
illary videomicroscopy, and other imaging strategies. Minimally 
invasive, low cost and patient friendly, CEU has proven itself as a 
validated and valuable technique to phenotype the microcirculation 
in metabolic, as well as blood pressure, research.
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